AstraZeneca COVID-19 vaccine trial suspended in US for at least several more days amid concerns over serious complication The experimental vaccine is drawing scrutiny after a participant in clinical trials was diagnosed with transverse myelitis, an inflammatory syndrome. The US clinical trial of AstraZeneca’s COVID-19 vaccine will be suspended for the next several days as the US Food and Drug Administration investigates a potential side effect, according to Reuters. Sources told the news agency on Monday that enrollment in the trial was not being reopened “until at least midweek,” pending the investigation. The FDA did not immediately respond to a request for comment.
Source: AstraZeneca suspends US COVID-19 vaccine trial amid serious concerns, trials continue in South Africa